Nanalysis Scientific (CVE:NSCI) Sets New 1-Year Low – Here’s Why

Nanalysis Scientific Corp. (CVE:NSCI) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as C$0.15 and last traded at C$0.15, with a volume of 100005 shares. The stock had previously closed at C$0.15.

Nanalysis Scientific Stock Performance

The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42. The stock has a 50 day moving average of C$0.16 and a 200 day moving average of C$0.18. The stock has a market capitalization of C$16.65 million, a P/E ratio of -1.45 and a beta of -0.88.

Nanalysis Scientific Company Profile

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.